Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixisenatide Monotherapy Titration Study in Japanese Patients with Type 2 Diabetes
NCT00905255Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2009
- Primary completion
- Jan 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started May 2009; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00905255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00905255.